(PharmaNewsWire.Com, November 16, 2017 ) Proteomics is the study of proteome which is a set of proteins present in the cell. Proteomes are different from one cell to another cell with requirements, stress, different time, and the organism. Proteomics help in the functioning and structure of the proteins used in the diagnosis, treatment, and drug discovery of various diseases. Moreover, proteomics also helps in the evaluation of protein production rate, interaction between the proteins, protein modification, and involvement in the metabolic pathways. Proteomics needs various equipment, instruments, media, reagents, and, software for the identification, quantification, and interactions between the proteins.
Increase in demand for personalized medicine, technological advancements for identification, increase in R&D activities by public and private sectors, and rise in the prevalence of genetic disorders expected to boost the proteomics market over the forecast period. Furthermore, rise in the number of biopharmaceutical and pharmaceutical companies, growing healthcare expenditure, and increasing innovations in the genomics field expected to propel the proteomics market. However, stringent regulatory policies, lack of professionals for R&D activities, and high cost of the devices and drugs might dampen the proteomics market revenue growth over the forecast period.
Proteomics market is segmented on the basis of product type, application, service type, and end user
Based on the product type, proteomics market is segmented into the following: • Instruments • Protein micro array • Spectroscopy • X-ray Crystallography • Chromatography • Electrophoresis • Protein fractionation system • Others • Reagents • Software
Based on the service type, proteomics market is segmented into the following: • Analytical laboratory services • Protein sequencing • Protein identification • Protein separation • Data analysis and maintenance • Others
Based on the application, proteomics market is segmented into the following: • Diagnosis • Treatment • Drug discovery • Others
Based on the end user, proteomics market is segmented into the following: • Biopharmaceutical and Pharmaceutical Companies • Chemical industries • Research institutes • Others
Proteomics market is growing at a significant CAGR owing to increase in the demand for personalized medicine and rise R&D activities by Biopharmaceutical companies and research institutes. Government’s initiatives for prevention the genetic disorders are a key factor for fuel the proteomics market over the forecast period. Acquisitions & mergers, collaborations, and innovations are some key strategies followed by the companies for increase their revenue in the proteomics market. For instance, in April 2014, Thermo Fisher Scientific has collaborated with Harward Medical School for the innovation of newer techniques for proteomics quantification. Similarly, in January 2012, Merck Millipore (Merck KGaA) has collaborated with Proteomics International for the evaluation of newly identified protein biomarkers under Merck’s multiplex immunoassays.
Geographically, proteomics market is segmented into North America, Asia Pacific, Latin America, Europe, and Middle East and Africa. The major factors anticipated to drive the North America proteomics market include the increase in funding from public and private sectors, developed healthcare infrastructure, increase in R&D activities, and increase in the demand for personalized medicine. Europe holds a key share in proteomics market, which is attributed to increase in the R&D activities for preventing the genetic disorders, technological advancements of instruments, and innovation of newer techniques are expected to propel the market in the region. Asia Pacific expected to exhibit lucrative growth over forecast timeframe owing to increase in the funding from public and private sectors, rise in demand for quality healthcare and personalized medicine in the region.
Some of the players in proteomics market are Merck KGaA (Germany), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Luminex Corporation (U.S.) to name a few.
About Precision Business Insights Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs. Contact to Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Email: sales@precisionbusinessinsights.com Toll Free (US): +1-866-598-1553 Website @ https://www.precisionbusinessinsights.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
